Research progress of clozapine-induced myocarditis
Clozapine (CLZ), as a unique and effective atypical antipsychotic drug, has achieved good results in the treatment of schizophrenia, but its cardiotoxicity has attracted the attention of clinicians. Clozapine-induced myocarditis (CIM) is a rare but serious cardiovascular adverse event during the use...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Guangxi Medical University
2024-08-01
|
| Series: | Guangxi Yike Daxue xuebao |
| Subjects: | |
| Online Access: | https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2024.08.016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Clozapine (CLZ), as a unique and effective atypical antipsychotic drug, has achieved good results in the treatment of schizophrenia, but its cardiotoxicity has attracted the attention of clinicians. Clozapine-induced myocarditis (CIM) is a rare but serious cardiovascular adverse event during the use of clozapine, the pathogenesis of which is unknown. The picture is further complicated by considering that people with schizophrenia may have cognitive impairments that make early heart damage difficult to detect. Therefore, this review summarizes the clinical manifestations, auxiliary examination characteristics, risk factors and possible pathogenesis of CIM, providing clues for doctors to diagnose, monitor and treat the CIM. |
|---|---|
| ISSN: | 1005-930X |